Clovis Oncology
CLVS
#10878
Rank
A$17.67 M
Marketcap
A$0.12
Share price
0.00%
Change (1 day)
-95.20%
Change (1 year)

EPS for Clovis Oncology (CLVS)

EPS in 2022 (TTM): A-$2.69

According to Clovis Oncology's latest financial reports the company's current EPS (TTM) is A-$2.84. In 2012 the company made an earnings per share (EPS) of A-$4.49.

EPS history for Clovis Oncology from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)A-$2.69
2012A-$4.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.03-453.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.07-137.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$8.79-409.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$46.39-1,734.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$10.69-476.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
BioMarin Pharmaceutical
BMRN
A-$0.14-95.24%๐Ÿ‡บ๐Ÿ‡ธ USA